Blood Monocyte Frequency May Be a Biomarker for Response to Anti-PD-1
- PMID: 29374020
- DOI: 10.1158/2159-8290.CD-RW2018-016
Blood Monocyte Frequency May Be a Biomarker for Response to Anti-PD-1
Abstract
CD14+CD16-HLA-DRhi monocyte frequency was linked to response to anti-PD-1 in patients with melanoma.
©2018 American Association for Cancer Research.
Comment on
-
High-dimensional single-cell analysis predicts response to anti-PD-1 immunotherapy.Nat Med. 2018 Feb;24(2):144-153. doi: 10.1038/nm.4466. Epub 2018 Jan 8. Nat Med. 2018. PMID: 29309059
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Research Materials